Takuro Sunada

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

EXTRAMEDULLARY HEMATOPOIESIS PRESENTING AS A RENAL MASS DURING TREATMENT OF CASTLEMAN DISEASE : A CASE REPORT

EXTRAMEDULLARY HEMATOPOIESIS PRESENTING AS A RENAL MASS DURING TREATMENT OF CASTLEMAN DISEASE : A CASE REPORT

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: August 05, 2026

A CASE OF PENILE PYODERMA GANGRENOSUM WITH STERILE ABSCESS SUCCESSFULLY TREATED WITH CORTICOSTEROIDS

A CASE OF PENILE PYODERMA GANGRENOSUM WITH STERILE ABSCESS SUCCESSFULLY TREATED WITH CORTICOSTEROIDS

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: June 30, 2026

DEVELOPMENT OF FATAL IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED ENCEPHALITIS FOLLOWING COMBINATION THERAPY WITH PEMBROLIZUMAB AND LENVATINIB IN A PATIENT WITH CLEAR CELL RENAL CELL CARCINOMA

DEVELOPMENT OF FATAL IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED ENCEPHALITIS FOLLOWING COMBINATION THERAPY WITH PEMBROLIZUMAB AND LENVATINIB IN A PATIENT WITH CLEAR CELL RENAL CELL CARCINOMA

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: June 04, 2026

Intraluminal hematoma of an ileal conduit causing postrenal acute kidney injury 14 years after radical cystectomy: A case report.

Intraluminal hematoma of an ileal conduit causing postrenal acute kidney injury 14 years after radical cystectomy: A case report.

Journal: Urology case reports

Published: May 17, 2026

Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate Cancer.

Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate Cancer.

Journal: The Prostate

Published: December 14, 2025

A Case of Pheochromocytoma Requiring Positioning and Approach Adjustments Due to Neurofibromatosis Type 1

A Case of Pheochromocytoma Requiring Positioning and Approach Adjustments Due to Neurofibromatosis Type 1

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: September 01, 2025

Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency.

Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency.

Journal: Molecular cancer therapeutics

Published: June 09, 2025

Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticity.

Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticity.

Journal: Frontiers in oncology

Published: February 14, 2025

A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma.

A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma.

Journal: Cancer medicine

Published: March 22, 2024

Defining the challenges and opportunities for using patient-derived models in prostate cancer research.

Defining the challenges and opportunities for using patient-derived models in prostate cancer research.

Journal: The Prostate

Published: December 14, 2023

A case of gangrenous cystitis with bilateral hydronephrosis 10 years after radiotherapy.

A case of gangrenous cystitis with bilateral hydronephrosis 10 years after radiotherapy.

Journal: Journal of general and family medicine

Published: January 18, 2023

ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen.

ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen.

Journal: Cell reports

Published: July 27, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026